CS logo
small CS logo
Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I

Trier, Germany

About Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I


During the past decade, Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I" #1 collaborator was "Amgen" with 1 trials as a collaborator and "Celgene Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I


According to Clinical.Site data, the most researched conditions in "Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I" are "Acute Myeloid Leukemia" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I" in a lesser frequency.

Clinical Trials Intervention Types at Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I


Most popular intervention types in "Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Fulvestrant" (1 trials), "Placebo" (1 trials), "Taselisib" (1 trials), "azacitidine" (1 trials) and "standard chemotherapy (7+3 scheme): Daunorubicin, Cytarabine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I


The vast majority of trials in "Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I" are 1 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I


Currently, there are NaN active trials in "Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".